March 14, 2025 · Form 4 insider transaction
Meisner Lara sold 48,720 shares of BICARA THERAPEUTICS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2024.; 25% of the shares underlying this option vested on November 27, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.